Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Wenping Gong, Yan Liang & Xueqiong Wu. (2018) The current status, challenges, and future developments of new tuberculosis vaccines. Human Vaccines & Immunotherapeutics 14:7, pages 1697-1716.
Read now
Read now
Steven Liang, David Bulir, Charu Kaushic & James Mahony. (2017) Considerations for the rational design of a Chlamydia vaccine. Human Vaccines & Immunotherapeutics 13:4, pages 831-835.
Read now
Read now
Sergio Rosales-Mendoza, Regina Ríos-Huerta & Carlos Angulo. (2015) An overview of tuberculosis plant-derived vaccines. Expert Review of Vaccines 14:6, pages 877-889.
Read now
Read now
Paola Gastelum-Aviña, Carlos Velazquez, Clara Espitia, Fernando Lares-Villa & Adriana Garibay-Escobar. (2015) A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design. Expert Review of Vaccines 14:5, pages 699-711.
Read now
Read now
Richard Voellmy, David C Bloom & Nuria Vilaboa. (2015) A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus. Expert Review of Vaccines 14:5, pages 637-651.
Read now
Read now
Articles from other publishers (25)
Li Zhuang, Zhaoyang Ye, Linsheng Li, Ling Yang & Wenping Gong. (2023) Next-Generation TB Vaccines: Progress, Challenges, and Prospects. Vaccines 11:8, pages 1304.
Crossref
Crossref
Jinjie Yu, Xueting Fan, Xiuli Luan, Ruihuan Wang, Bin Cao, Chengyu Qian, Guilian Li, Machao Li, Xiuqin Zhao, Haican Liu, Kanglin Wan & Xiuqin Yuan. (2023) A novel multi-component protein vaccine ECP001 containing a protein polypeptide antigen nPstS1 riching in T-cell epitopes showed good immunogenicity and protection in mice. Frontiers in Immunology 14.
Crossref
Crossref
Michel P.M. Vierboom, Karin Dijkman, Claudia C. Sombroek, Sam O. Hofman, Charelle Boot, Richard A.W. Vervenne, Krista G. Haanstra, Maarten van der Sande, Liesbeth van Emst, Jorge Domínguez-Andrés, Simone J.C.F.M. Moorlag, Clemens H.M. Kocken, Jelle Thole, Esteban Rodríguez, Eugenia Puentes, Joost H.A. Martens, Reinout van Crevel, Mihai G. Netea, Nacho Aguilo, Carlos Martin & Frank A.W. Verreck. (2021) Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination. Cell Reports Medicine 2:1, pages 100185.
Crossref
Crossref
Carlos Martin, Nacho Aguilo, Dessislava Marinova & Jesus Gonzalo-Asensio. (2020) Update on TB Vaccine Pipeline. Applied Sciences 10:7, pages 2632.
Crossref
Crossref
Jesus Gonzalo-asensio, Nacho Aguilo, Dessislava Marinova & Carlos Martin. 2019. Microbial Transmission. Microbial Transmission
249
261
.
J.S.V. Soundarya, Uma Devi Ranganathan & Srikanth P. Tripathy. (2019) Current trends in tuberculosis vaccine. Medical Journal Armed Forces India 75:1, pages 18-24.
Crossref
Crossref
Hadi Peerdogaheh, Roghayeh Teimourpour, Bagher Moradi, Mahdi Yousefipour, Aida Gholoobi, Akram Baghani & Zahra Meshkat. (2018) Evaluation of Immune Responses to a DNA Vaccine Encoding Ag85a-Cfp10 Antigen of Mycobacterium tuberculosis in an Animal Model. Jundishapur Journal of Microbiology In Press:In Press.
Crossref
Crossref
Carlos Martin, Nacho Aguilo & Jesús Gonzalo-Asensio. (2018) Vaccination against tuberculosis. Enfermedades infecciosas y microbiologia clinica (English ed.) 36:10, pages 648-656.
Crossref
Crossref
Carlos Martin, Nacho Aguilo & Jesús Gonzalo-Asensio. (2018) Vacunación frente a tuberculosis. Enfermedades Infecciosas y Microbiología Clínica 36:10, pages 648-656.
Crossref
Crossref
Sourya Shrestha, Violet Chihota, Richard G White, Alison D Grant, Gavin J Churchyard & David W Dowdy. (2017) Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based Study. American Journal of Epidemiology 186:12, pages 1362-1369.
Crossref
Crossref
Jesus Gonzalo-Asensio, Nacho Aguilo, Dessislava Marinova & Carlos Martin. (2017) Breaking Transmission with Vaccines: The Case of Tuberculosis. Microbiology Spectrum 5:4.
Crossref
Crossref
Nacho Aguilo, Jesus Gonzalo-Asensio, Samuel Alvarez-Arguedas, Dessislava Marinova, Ana Belen Gomez, Santiago Uranga, Ralf Spallek, Mahavir Singh, Regine Audran, François Spertini & Carlos Martin. (2017) Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis. Nature Communications 8:1.
Crossref
Crossref
Federico Martinon-Torres & Carlos Martin. 2017. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
149
160
.
Nancy Gupta, Satish Vedi, Dennis Y. Kunimoto, Babita Agrawal & Rakesh Kumar. (2016) Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis : Routes of immunization and TLR agonists critically impact vaccine’s efficacy. Vaccine 34:46, pages 5677-5688.
Crossref
Crossref
Sourya Shrestha, Susmita Chatterjee, Krishna D. Rao & David W. Dowdy. (2016) Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India. Journal of The Royal Society Interface 13:116, pages 20151016.
Crossref
Crossref
Sergio Arregui, Joaquín Sanz, Dessislava Marinova, Carlos Martín & Yamir Moreno. (2016) On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines. PeerJ 4, pages e1513.
Crossref
Crossref
Nacho Aguilo, Santiago Uranga, Dessislava Marinova, Marta Monzon, Juan Badiola & Carlos Martin. (2016) MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice. Tuberculosis 96, pages 71-74.
Crossref
Crossref
François Spertini, Régine Audran, Reza Chakour, Olfa Karoui, Viviane Steiner-Monard, Anne-Christine Thierry, Carole E Mayor, Nils Rettby, Katia Jaton, Laure Vallotton, Catherine Lazor-Blanchet, Juana Doce, Eugenia Puentes, Dessislava Marinova, Nacho Aguilo & Carlos Martin. (2015) Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial. The Lancet Respiratory Medicine 3:12, pages 953-962.
Crossref
Crossref
Jianhua Zheng, Liguo Liu, Bo Liu & Qi Jin. (2015) Phosphoproteomic analysis of bacillus Calmette–Guérin using gel-based and gel-free approaches. Journal of Proteomics 126, pages 189-199.
Crossref
Crossref
M.-J. Iglesias & C. Martin. (2015) Editorial Commentary: Nonspecific Beneficial Effects of BCG Vaccination in High-income Countries, Should We Extend Recommendation of BCG Vaccination?. Clinical Infectious Diseases 60:11, pages 1620-1621.
Crossref
Crossref
W. R. Waters & M. V. Palmer. (2015) Mycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human Tuberculosis. ILAR Journal 56:1, pages 26-43.
Crossref
Crossref
Luis Solans, Santiago Uranga, Nacho Aguilo, Carmen Arnal, Ana Belen Gomez, Marta Monzon, Juan Jose Badiola, Brigitte Gicquel & Carlos Martin. (2014) Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice. Vaccine 32:40, pages 5192-5197.
Crossref
Crossref
Wayne C Koff, Ian D Gust & Stanley A Plotkin. (2014) Toward a Human Vaccines Project. Nature Immunology 15:7, pages 589-592.
Crossref
Crossref
Nacho Aguilo, Ana Maria Toledo, Eva Maria Lopez-Roman, Esther Perez-Herran, Eamonn Gormley, Joaquin Rullas-Trincado, Iñigo Angulo-Barturen & Carlos Martin. (2014) Pulmonary Mycobacterium bovis BCG Vaccination Confers Dose-Dependent Superior Protection Compared to That of Subcutaneous Vaccination. Clinical and Vaccine Immunology 21:4, pages 594-597.
Crossref
Crossref
Rupanjali Chaudhuri, Deepika Kulshreshtha, Muthukurussi Varieth Raghunandanan & Srinivasan Ramachandran. (2014) Integrative immunoinformatics for Mycobacterial diseases in R platform. Systems and Synthetic Biology 8:1, pages 27-39.
Crossref
Crossref